Buy Jubilant Life Sciences; target of Rs 750: Dolat Capital

Buy Jubilant Life Sciences; target of Rs 750: Dolat Capital Dolat Capital is bullish on Jubilant Life Sciences has recommended Buy rating on the stock with a target price of Rs 750 in its research report dated May 21, 2019.

Add a Comment

Your email address will not be published. Required fields are marked *